Gene Symbol |
Definition |
Felxi PID |
Halo PID |
Nluc-N PID |
Nluc-C PID |
PIP5K1C |
phosphatidylinositol-4-phosphate 5-kinase, type I, gamma, transcript variant 2 |
FXC00103
|
FHC00103
|
FNC00103N
|
FNC00103C
|
CYFIP2 |
cytoplasmic FMR1 interacting protein 2, transcript variant 5 |
FXC00193
|
FHC00193
|
FNC00193N
|
FNC00193C
|
MYH14 |
myosin, heavy chain 14, non-muscle, transcript variant 3 |
FXC00313
|
FHC00313
|
FNC00313N
|
FNC00313C
|
LIMK1 |
LIM domain kinase 1, transcript variant 1 |
FXC00359
|
FHC00359
|
FNC00359N
|
FNC00359C
|
ARHGEF7 |
Rho guanine nucleotide exchange factor (GEF) 7, transcript variant 1 |
FXC00426
|
FHC00426
|
FNC00426N
|
FNC00426C
|
PXDN |
peroxidasin |
FXC00470
|
FHC00470
|
FNC00470N
|
FNC00470C
|
WASF1 |
WAS protein family, member 1, transcript variant 1 |
FXC00484
|
FHC00484
|
FNC00484N
|
FNC00484C
|
ARHGEF4 |
Rho guanine nucleotide exchange factor (GEF) 4, transcript variant 2 |
FXC00742
|
FHC00742
|
FNC00742N
|
FNC00742C
|
PAK4 |
p21 protein (Cdc42/Rac)-activated kinase 4, transcript variant 5 |
FXC00749
|
FHC00749
|
FNC00749N
|
FNC00749C
|
PAK5 |
p21 (RAC1) activated kinase 5 (PAK5), transcript variant 1 |
FXC00788
|
FHC00788
|
FNC00788N
|
FNC00788C
|
ARHGAP35 |
Rho GTPase activating protein 35 |
FXC00901
|
FHC00901
|
FNC00901N
|
FNC00901C
|
ITGA7 |
integrin, alpha 7, transcript variant 2 |
FXC01003
|
FHC01003
|
FNC01003N
|
FNC01003C
|
PAK6 |
p21 protein (Cdc42/Rac)-activated kinase 6, transcript variant 1 |
FXC01015
|
FHC01015
|
FNC01015N
|
FNC01015C
|
IQGAP1 |
IQ motif containing GTPase activating protein 1 |
FXC01050
|
FHC01050
|
FNC01050N
|
FNC01050C
|
CYFIP1 |
cytoplasmic FMR1 interacting protein 1, transcript variant 1 |
FXC01053
|
FHC01053
|
FNC01053N
|
FNC01053C
|
ROCK2 |
Rho-associated, coiled-coil containing protein kinase 2 |
FXC01105
|
FHC01105
|
FNC01105N
|
FNC01105C
|
FN1 |
fibronectin 1 |
FXC01189
|
FHC01189
|
FNC01189N
|
FNC01189C
|
APC |
adenomatous polyposis coli, transcript variant 3 |
FXC01190
|
FHC01190
|
FNC01190N
|
FNC01190C
|
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
FXC01204
|
FHC01204
|
FNC01204N
|
FNC01204C
|
MYLK |
myosin light chain kinase, transcript variant 1 |
FXC01214
|
FHC01214
|
FNC01214N
|
FNC01214C
|
DIAPH2 |
diaphanous-related formin 2 |
FXC01217
|
FHC01217
|
FNC01217N
|
FNC01217C
|
ITGB7 |
integrin, beta 7, transcript variant 1 |
FXC01226
|
FHC01226
|
FNC01226N
|
FNC01226C
|
ITGAM |
integrin, alpha M (complement component 3 receptor 3 subunit), transcript variant 2 |
FXC01233
|
FHC01233
|
FNC01233N
|
FNC01233C
|
ITGAD |
integrin, alpha D |
FXC01279
|
FHC01279
|
FNC01279N
|
FNC01279C
|
FGD1 |
FYVE, RhoGEF and PH domain containing 1 |
FXC01312
|
FHC01312
|
FNC01312N
|
FNC01312C
|
PIK3CB |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, transcript variant 1 |
FXC01319
|
FHC01319
|
FNC01319N
|
FNC01319C
|
PIK3R3 |
phosphoinositide-3-kinase, regulatory subunit 3 (gamma), transcript variant 1 |
FXC01326
|
FHC01326
|
FNC01326N
|
FNC01326C
|
MAPK1 |
mitogen-activated protein kinase 1, transcript variant 1 |
FXC01388
|
FHC01388
|
FNC01388N
|
FNC01388C
|
DIAPH1 |
diaphanous-related formin 1, transcript variant 1 |
FXC01409
|
FHC01409
|
FNC01409N
|
FNC01409C
|
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
FXC01412
|
FHC01412
|
FNC01412N
|
FNC01412C
|
ITGA5 |
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
FXC01471
|
FHC01471
|
FNC01471N
|
FNC01471C
|
MAPK3 |
mitogen-activated protein kinase 3, transcript variant 1 |
FXC01500
|
FHC01500
|
FNC01500N
|
FNC01500C
|
CHRM1 |
cholinergic receptor, muscarinic 1 |
FXC01507
|
FHC01507
|
FNC01507N
|
FNC01507C
|
RHOA |
ras homolog family member A |
FXC01522
|
FHC01522
|
FNC01522N
|
FNC01522C
|
ACTB |
actin, beta |
FXC01523
|
FHC01523
|
FNC01523N
|
FNC01523C
|
NCOA3 |
nuclear receptor coactivator 3, transcript variant 3 |
FXC01529
|
FHC01529
|
FNC01529N
|
FNC01529C
|
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
FXC01574
|
FHC01574
|
FNC01574N
|
FNC01574C
|
NCKAP1 |
NCK-associated protein 1, transcript variant 2 |
FXC01597
|
FHC01597
|
FNC01597N
|
FNC01597C
|
MYH9 |
myosin, heavy chain 9, non-muscle |
FXC01643
|
FHC01643
|
FNC01643N
|
FNC01643C
|
GIT1 |
G protein-coupled receptor kinase interacting ArfGAP 1, transcript variant 1 |
FXC01778
|
FHC01778
|
FNC01778N
|
FNC01778C
|
VCL |
vinculin, transcript variant 2 |
FXC01835
|
FHC01835
|
FNC01835N
|
FNC01835C
|
PIK3R2 |
phosphoinositide-3-kinase, regulatory subunit 2 (beta), transcript variant 1 |
FXC01882
|
FHC01882
|
FNC01882N
|
FNC01882C
|
ITGA2 |
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor), transcript variant 1 |
FXC01888
|
FHC01888
|
FNC01888N
|
FNC01888C
|
MYH10 |
myosin, heavy chain 10, non-muscle, transcript variant 1 |
FXC02063
|
FHC02063
|
FNC02063N
|
FNC02063C
|
PPP1CB |
protein phosphatase 1, catalytic subunit, beta isozyme, transcript variant 1 |
FXC02071
|
FHC02071
|
FNC02071N
|
FNC02071C
|
GNA12 |
guanine nucleotide binding protein (G protein) alpha 12, transcript variant 1 |
FXC02119
|
FHC02119
|
FNC02119N
|
FNC02119C
|
GNG12 |
guanine nucleotide binding protein (G protein), gamma 12 |
FXC02211
|
FHC02211
|
FNC02211N
|
FNC02211C
|
PDGFA |
platelet-derived growth factor alpha polypeptide, transcript variant 2 |
FXC02363
|
FHC02363
|
FNC02363N
|
FNC02363C
|
SOS2 |
son of sevenless homolog 2 (Drosophila) |
FXC02373
|
FHC02373
|
FNC02373N
|
FNC02373C
|
SOS1 |
son of sevenless homolog 1 (Drosophila) |
FXC02380
|
FHC02380
|
FNC02380N
|
FNC02380C
|
VPS72 |
vacuolar protein sorting 72 homolog (S. cerevisiae), transcript variant 2 |
FXC02546
|
FHC02546
|
FNC02546N
|
FNC02546C
|
PFN2 |
profilin 2, transcript variant 1 |
FXC02625
|
FHC02625
|
FNC02625N
|
FNC02625C
|
ARPC1B |
actin related protein 2/3 complex, subunit 1B, 41kDa |
FXC02656
|
FHC02656
|
FNC02656N
|
FNC02656C
|
RAC1 |
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1), transcript variant Rac1 |
FXC02699
|
FHC02699
|
FNC02699N
|
FNC02699C
|
CRKL |
v-crk avian sarcoma virus CT10 oncogene homolog-like |
FXC02842
|
FHC02842
|
FNC02842N
|
FNC02842C
|
RAC2 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
FXC02856
|
FHC02856
|
FNC02856N
|
FNC02856C
|
CHRM2 |
cholinergic receptor, muscarinic 2, transcript variant 4 |
FXC03057
|
FHC03057
|
FNC03057N
|
FNC03057C
|
BDKRB2 |
bradykinin receptor B2 |
FXC03132
|
FHC03132
|
FNC03132N
|
FNC03132C
|
ITGB1 |
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12), transcript variant 1A |
FXC03293
|
FHC03293
|
FNC03293N
|
FNC03293C
|
MOS |
v-mos Moloney murine sarcoma viral oncogene homolog |
FXC03345
|
FHC03345
|
FNC03345N
|
FNC03345C
|
RDX |
radixin, transcript variant 3 |
FXC03460
|
FHC03460
|
FNC03460N
|
FNC03460C
|
SSH3 |
slingshot protein phosphatase 3 |
FXC03599
|
FHC03599
|
FNC03599N
|
FNC03599C
|
HRAS |
Harvey rat sarcoma viral oncogene homolog, transcript variant 1 |
FXC03635
|
FHC03635
|
FNC03635N
|
FNC03635C
|
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit), transcript variant 1 |
FXC03720
|
FHC03720
|
FNC03720N
|
FNC03720C
|
WASF2 |
WAS protein family, member 2, transcript variant 1 |
FXC03721
|
FHC03721
|
FNC03721N
|
FNC03721C
|
PKN1 |
protein kinase N1, transcript variant 1 |
FXC03745
|
FHC03745
|
FNC03745N
|
FNC03745C
|
PKN2 |
protein kinase N2 |
FXC03784
|
FHC03784
|
FNC03784N
|
FNC03784C
|
ARPC3 |
actin related protein 2/3 complex, subunit 3, 21kDa, transcript variant 1 |
FXC03896
|
FHC03896
|
FNC03896N
|
FNC03896C
|
ITGA2B |
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) |
FXC03930
|
FHC03930
|
FNC03930N
|
FNC03930C
|
ARHGEF6 |
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6, transcript variant 1 |
FXC04167
|
FHC04167
|
FNC04167N
|
FNC04167C
|
ARPC2 |
actin related protein 2/3 complex, subunit 2, 34kDa, transcript variant 2 |
FXC04181
|
FHC04181
|
FNC04181N
|
FNC04181C
|
CD14 |
CD14 molecule, transcript variant 1 |
FXC04493
|
FHC04493
|
FNC04493N
|
FNC04493C
|
FGF5 |
fibroblast growth factor 5, transcript variant 1 |
FXC05019
|
FHC05019
|
FNC05019N
|
FNC05019C
|
ITGA4 |
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) |
FXC05544
|
FHC05544
|
FNC05544N
|
FNC05544C
|
ITGAV |
integrin, alpha V, transcript variant 3 |
FXC05547
|
FHC05547
|
FNC05547N
|
FNC05547C
|
LIMK2 |
LIM domain kinase 2, transcript variant 2a |
FXC05834
|
FHC05834
|
FNC05834N
|
FNC05834C
|
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
FXC05918
|
FHC05918
|
FNC05918N
|
FNC05918C
|
VAV2 |
vav 2 guanine nucleotide exchange factor, transcript variant 2 |
FXC05989
|
FHC05989
|
FNC05989N
|
FNC05989C
|
MYH7B |
myosin, heavy chain 7B, cardiac muscle, beta |
FXC06072
|
FHC06072
|
FNC06072N
|
FNC06072C
|
MYL10 |
myosin, light chain 10, regulatory |
FXC06081
|
FHC06081
|
FNC06081N
|
FNC06081C
|
PDGFB |
platelet-derived growth factor beta polypeptide, transcript variant 1 |
FXC06311
|
FHC06311
|
FNC06311N
|
FNC06311C
|
PFN1 |
profilin 1 |
FXC06337
|
FHC06337
|
FNC06337N
|
FNC06337C
|
PPP1CA |
protein phosphatase 1, catalytic subunit, alpha isozyme, transcript variant 2 |
FXC06454
|
FHC06454
|
FNC06454N
|
FNC06454C
|
PIP4K2C |
phosphatidylinositol-5-phosphate 4-kinase, type II, gamma, transcript variant 1 |
FXC07626
|
FHC07626
|
FNC07626N
|
FNC07626C
|
ACTG1 |
actin gamma 1, transcript variant 2 |
FXC07847
|
FHC07847
|
FNC07847N
|
FNC07847C
|
ARAF |
A-Raf proto-oncogene, serine/threonine kinase, transcript variant 1 |
FXC08066
|
FHC08066
|
FNC08066N
|
FNC08066C
|
ACTN4 |
actinin, alpha 4 |
FXC08216
|
FHC08216
|
FNC08216N
|
FNC08216C
|
INS |
insulin, transcript variant 1 |
FXC08231
|
FHC08231
|
FNC08231N
|
FNC08231C
|
FGF18 |
fibroblast growth factor 18 |
FXC08269
|
FHC08269
|
FNC08269N
|
FNC08269C
|
CRK |
v-crk avian sarcoma virus CT10 oncogene homolog, transcript variant II |
FXC08374
|
FHC08374
|
FNC08374N
|
FNC08374C
|
RAC3 |
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
FXC08439
|
FHC08439
|
FNC08439N
|
FNC08439C
|
WAS |
Wiskott-Aldrich syndrome |
FXC08646
|
FHC08646
|
FNC08646N
|
FNC08646C
|
EZR |
ezrin, transcript variant 1 |
FXC08715
|
FHC08715
|
FNC08715N
|
FNC08715C
|
ACTN1 |
actinin, alpha 1, transcript variant 2 |
FXC08813
|
FHC08813
|
FNC08813N
|
FNC08813C
|
CFL1 |
cofilin 1 (non-muscle) |
FXC08956
|
FHC08956
|
FNC08956N
|
FNC08956C
|
FGF12 |
fibroblast growth factor 12, transcript variant 2 |
FXC09106
|
FHC09106
|
FNC09106N
|
FNC09106C
|
PIP5K1B |
phosphatidylinositol-4-phosphate 5-kinase, type I, beta |
FXC09332
|
FHC09332
|
FNC09332N
|
FNC09332C
|
BDKRB1 |
bradykinin receptor B1 |
FXC09533
|
FHC09533
|
FNC09533N
|
FNC09533C
|
GNA13 |
guanine nucleotide binding protein (G protein), alpha 13, transcript variant 1 |
FXC09630
|
FHC09630
|
FNC09630N
|
FNC09630C
|
EGFR |
epidermal growth factor receptor, transcript variant 1 |
FXC09683
|
FHC09683
|
FNC09683N
|
FNC09683C
|
ABI2 |
abl-interactor 2, transcript variant 3 |
FXC09766
|
FHC09766
|
FNC09766N
|
FNC09766C
|
F2R |
coagulation factor II thrombin receptor, transcript variant 1 |
FXC09792
|
FHC09792
|
FNC09792N
|
FNC09792C
|
FGFR4 |
fibroblast growth factor receptor 4, transcript variant 1 |
FXC09979
|
FHC09979
|
FNC09979N
|
FNC09979C
|
FGF13 |
fibroblast growth factor 13, transcript variant 1 |
FXC09990
|
FHC09990
|
FNC09990N
|
FNC09990C
|
MYL2 |
myosin, light chain 2, regulatory, cardiac, slow |
FXC10057
|
FHC10057
|
FNC10057N
|
FNC10057C
|
MYL12A |
myosin, light chain 12A, regulatory, non-sarcomeric, transcript variant 1 |
FXC10070
|
FHC10070
|
FNC10070N
|
FNC10070C
|
FGF21 |
fibroblast growth factor 21 |
FXC10096
|
FHC10096
|
FNC10096N
|
FNC10096C
|
SCIN |
scinderin, transcript variant 1 |
FXC10132
|
FHC10132
|
FNC10132N
|
FNC10132C
|
ANAPC2 |
anaphase promoting complex subunit 2 |
FXC10289
|
FHC10289
|
FNC10289N
|
FNC10289C
|
ARHGEF1 |
Rho guanine nucleotide exchange factor (GEF) 1, transcript variant 2 |
FXC10306
|
FHC10306
|
FNC10306N
|
FNC10306C
|
PROC |
protein C (inactivator of coagulation factors Va and VIIIa) |
FXC10312
|
FHC10312
|
FNC10312N
|
FNC10312C
|
ITGAX |
integrin, alpha X (complement component 3 receptor 4 subunit), transcript variant 1 |
FXC10352
|
FHC10352
|
FNC10352N
|
FNC10352C
|
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
FXC10375
|
FHC10375
|
FNC10375N
|
FNC10375C
|
VAV3 |
vav 3 guanine nucleotide exchange factor, transcript variant 1 |
FXC10465
|
FHC10465
|
FNC10465N
|
FNC10465C
|
FGFR3 |
fibroblast growth factor receptor 3
|
FXC10468
|
FHC10468
|
|
|
FGFR3 |
fibroblast growth factor receptor 3, transcript variant 1 |
FXC10478
|
FHC10478
|
FNC10478N
|
FNC10478C
|
MSN |
moesin |
FXC10494
|
FHC10494
|
FNC10494N
|
FNC10494C
|
FGFR1 |
fibroblast growth factor receptor 1, transcript variant 3 |
FXC10532
|
FHC10532
|
FNC10532N
|
FNC10532C
|
FGF1 |
fibroblast growth factor 1 (acidic), transcript variant 1 |
FXC10599
|
FHC10599
|
FNC10599N
|
FNC10599C
|
RRAS2 |
related RAS viral (r-ras) oncogene homolog 2, transcript variant 1 |
FXC10622
|
FHC10622
|
FNC10622N
|
FNC10622C
|
RRAS |
related RAS viral (r-ras) oncogene homolog |
FXC10666
|
FHC10666
|
FNC10666N
|
FNC10666C
|
BAIAP2 |
BAI1-associated protein 2, transcript variant 2 |
FXC10688
|
FHC10688
|
FNC10688N
|
FNC10688C
|
CLSTN1 |
calsyntenin 1, transcript variant 1 |
FXC10700
|
FHC10700
|
FNC10700N
|
FNC10700C
|
ITGB5 |
integrin, beta 5 |
FXC10710
|
FHC10710
|
FNC10710N
|
FNC10710C
|
KRAS |
Kirsten rat sarcoma viral oncogene homolog, transcript variant b |
FXC10770
|
FHC10770
|
FNC10770N
|
FNC10770C
|
PDGFB |
platelet-derived growth factor beta polypeptide |
FXC10772
|
FHC10772
|
FNC10772N
|
FNC10772C
|
CHRM3 |
cholinergic receptor, muscarinic 3 |
FXC10778
|
FHC10778
|
FNC10778N
|
FNC10778C
|
ITGB3 |
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
FXC10787
|
FHC10787
|
FNC10787N
|
FNC10787C
|
FGF11 |
fibroblast growth factor 11, transcript variant 1 |
FXC10818
|
FHC10818
|
FNC10818N
|
FNC10818C
|
PXN |
paxillin, transcript variant 1 |
FXC10852
|
FHC10852
|
FNC10852N
|
FNC10852C
|
ARPC5 |
actin related protein 2/3 complex, subunit 5, 16kDa, transcript variant 1 |
FXC10908
|
FHC10908
|
FNC10908N
|
FNC10908C
|
MRAS |
muscle RAS oncogene homolog, transcript variant 1 |
FXC10922
|
FHC10922
|
FNC10922N
|
FNC10922C
|
PPP1CC |
protein phosphatase 1, catalytic subunit, gamma isozyme, transcript variant 2 |
FXC10941
|
FHC10941
|
FNC10941N
|
FNC10941C
|
PIP5K1A |
phosphatidylinositol-4-phosphate 5-kinase, type I, alpha, transcript variant 2 |
FXC10989
|
FHC10989
|
FNC10989N
|
FNC10989C
|
ACTN2 |
actinin, alpha 2, transcript variant 1 |
FXC11021
|
FHC11021
|
FNC11021N
|
FNC11021C
|
PRF1 |
perforin 1 (pore forming protein), transcript variant 1 |
FXC11041
|
FHC11041
|
FNC11041N
|
FNC11041C
|
FGF16 |
fibroblast growth factor 16 |
FXC11178
|
FHC11178
|
FNC11178N
|
FNC11178C
|
MYLK4 |
myosin light chain kinase family, member 4 |
FXC11219
|
FHC11219
|
FNC11219N
|
FNC11219C
|
MYLK2 |
myosin light chain kinase 2 |
FXC11428
|
FHC11428
|
FNC11428N
|
FNC11428C
|
NRAS |
neuroblastoma RAS viral (v-ras) oncogene homolog |
FXC11491
|
FHC11491
|
FNC11491N
|
FNC11491C
|
CDC42 |
cell division cycle 42, transcript variant 2 |
FXC11496
|
FHC11496
|
FNC11496N
|
FNC11496C
|
PIP4K2B |
phosphatidylinositol-5-phosphate 4-kinase, type II, beta |
FXC11516
|
FHC11516
|
FNC11516N
|
FNC11516C
|
ARHGEF12 |
Rho guanine nucleotide exchange factor (GEF) 12, transcript variant 1 |
FXC11597
|
FHC11597
|
FNC11597N
|
FNC11597C
|
IQGAP3 |
IQ motif containing GTPase activating protein 3 |
FXC11605
|
FHC11605
|
FNC11605N
|
FNC11605C
|
FGF3 |
fibroblast growth factor 3 |
FXC11767
|
FHC11767
|
FNC11767N
|
FNC11767C
|
BCAR1 |
breast cancer anti-estrogen resistance 1, transcript variant 6 |
FXC11824
|
FHC11824
|
FNC11824N
|
FNC11824C
|
SRC |
SRC proto-oncogene, non-receptor tyrosine kinase, transcript variant 1 |
FXC11854
|
FHC11854
|
FNC11854N
|
FNC11854C
|
BRAF |
B-Raf proto-oncogene, serine/threonine kinase |
FXC11883
|
FHC11883
|
FNC11883N
|
FNC11883C
|
ITGA8 |
integrin, alpha 8, transcript variant 1 |
FXC11884
|
FHC11884
|
FNC11884N
|
FNC11884C
|
WASL |
Wiskott-Aldrich syndrome-like |
FXC11943
|
FHC11943
|
FNC11943N
|
FNC11943C
|
PAK3 |
p21 protein (Cdc42/Rac)-activated kinase 3, transcript variant 2 |
FXC12049
|
FHC12049
|
FNC12049N
|
FNC12049C
|
PDGFRA |
platelet derived growth factor receptor alpha |
FXC12575
|
FHC12575
|
FNC12575N
|
FNC12575C
|
MYLK3 |
myosin light chain kinase 3, transcript variant 1 |
FXC12580
|
FHC12580
|
FNC12580N
|
FNC12580C
|
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
FXC12640
|
FHC12640
|
FNC12640N
|
FNC12640C
|
PTK2 |
protein tyrosine kinase 2, transcript variant 1 |
FXC12651
|
FHC12651
|
FNC12651N
|
FNC12651C
|
PAK2 |
p21 protein (Cdc42/Rac)-activated kinase 2 |
FXC16509
|
FHC16509
|
FNC16509N
|
FNC16509C
|
PIKFYVE |
phosphoinositide kinase, FYVE finger containing, transcript variant 2 |
FXC21300
|
FHC21300
|
FNC21300N
|
FNC21300C
|
PDGFC |
platelet derived growth factor C, transcript variant 1 |
FXC22085
|
FHC22085
|
FNC22085N
|
FNC22085C
|
FGF10 |
fibroblast growth factor 10 |
FXC22164
|
FHC22164
|
FNC22164N
|
FNC22164C
|
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha), transcript variant 2 |
FXC22191
|
FHC22191
|
FNC22191N
|
FNC22191C
|
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, transcript variant 1 |
FXC23046
|
FHC23046
|
|
|
FGF20 |
fibroblast growth factor 20 |
FXC23199
|
FHC23199
|
FNC23199N
|
FNC23199C
|
FGF17 |
fibroblast growth factor 17, transcript variant 1 |
FXC23209
|
FHC23209
|
FNC23209N
|
FNC23209C
|
PIP4K2A |
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha |
FXC23792
|
FHC23792
|
FNC23792N
|
FNC23792C
|
FGFR2 |
fibroblast growth factor receptor 2, transcript variant 1 |
FXC24041
|
FHC24041
|
FNC24041N
|
FNC24041C
|
FGFR2 |
fibroblast growth factor receptor 2, transcript variant 9 |
FXC24045
|
FHC24045
|
|
|
FGF19 |
fibroblast growth factor 19 |
FXC24356
|
FHC24356
|
FNC24356N
|
FNC24356C
|
FGF4 |
fibroblast growth factor 4 |
FXC24357
|
FHC24357
|
FNC24357N
|
FNC24357C
|
FGF23 |
fibroblast growth factor 23
|
FXC24560
|
FHC24560
|
|
|
FGF9 |
fibroblast growth factor 9 |
FXC24958
|
FHC24958
|
FNC24958N
|
FNC24958C
|
FGF14 |
fibroblast growth factor 14, transcript variant 2 |
FXC25055
|
FHC25055
|
FNC25055N
|
FNC25055C
|
RNASE1 |
ribonuclease, RNase A family, 1 (pancreatic), transcript variant 4 |
FXC25083
|
FHC25083
|
FNC25083N
|
FNC25083C
|
CHRM5 |
cholinergic receptor, muscarinic 5 |
FXC25325
|
FHC25325
|
FNC25325N
|
FNC25325C
|
FGF7 |
fibroblast growth factor 7 |
FXC25383
|
FHC25383
|
FNC25383N
|
FNC25383C
|
ITGA3 |
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor), transcript variant a
|
FXC26102
|
FHC26102
|
|
|
ROCK1 |
Rho-associated, coiled-coil containing protein kinase 1 |
FXC26266
|
FHC26266
|
FNC26266N
|
FNC26266C
|
VAV1 |
vav 1 guanine nucleotide exchange factor, transcript variant 1 |
FXC26428
|
FHC26428
|
FNC26428N
|
FNC26428C
|
TIAM1 |
T-cell lymphoma invasion and metastasis 1
|
FXC27150
|
FHC27150
|
|
|
ENAH |
enabled homolog (Drosophila), transcript variant 1 |
FXC27775
|
FHC27775
|
FNC27775N
|
FNC27775C
|
CHRM4 |
cholinergic receptor, muscarinic 4 |
FXC30477
|
FHC30477
|
FNC30477N
|
FNC30477C
|
F2 |
coagulation factor II (thrombin), transcript variant 1 |
FXC31633
|
FHC31633
|
FNC31633N
|
FNC31633C
|